Gemcitabine and oxaliplatin: a safe and active regimen in poor prognosis advanced non-small cell lung cancer patients
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2015 ◽
Vol 18
(4)
◽
pp. 360-368
◽
Keyword(s):
Keyword(s):
Keyword(s):